Dr. Olga Kavalchuk

MMJ FDA Genetics Advisor

Dr. Kovalchuk received her B. Med. (Honors, 1992) and M.D. (Stomatology, 1994) degrees at the Ivano-Frankivsk National Medical University in Ukraine. In 1994 she began a career at the Medical University and the Chernobyl Research Centre studying consequences of the Chernobyl accident, and in 1998 received a PhD (Medical Genetics). Dr. Kovalchuk conducted extensive postdoctoral training at the Friedrich Miescher Institut and in Novartis/Syngenta (Switzerland). Currently Dr. Kovalchuk is a Professor, Board of Governors’ Research Chair, and the CIHR Chair in Gender, Work and Health at the University of Lethbridge. Dr. Kovalchuk is an expert in radiation biology, oncology and epigenetics. She is a co-founder of the Canada Cancer and Aging Research Laboratories, a research and development company offering a personalized approach to cancer treatment.